Wells Fargo’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-24
Closed -$652 – 6910
2024
Q1
$652 Buy
24
+1
+4% +$32 ﹤0.01% 6238
2023
Q4
$569 Sell
23
-1,260
-98% -$22.3K ﹤0.01% 6352
2023
Q3
$25.9K Hold
1,283
– – ﹤0.01% 5494
2023
Q2
$37.9K Sell
1,283
-581
-31% -$16.6K ﹤0.01% 5531
2023
Q1
$46.6K Buy
1,864
+603
+48% +$19.4K ﹤0.01% 5190
2022
Q4
$40K Sell
1,261
-7
-0.6% -$221 ﹤0.01% 4965
2022
Q3
$37K Sell
1,268
-46
-4% -$1.59K ﹤0.01% 5085
2022
Q2
$40K Sell
1,314
-287
-18% -$26.3K ﹤0.01% 5123
2022
Q1
$216K Sell
1,601
-1,122
-41% -$118K ﹤0.01% 4936
2021
Q4
$354K Buy
2,723
+2,713
+27,130% +$343K ﹤0.01% 4934
2021
Q3
$1K Sell
10
-448
-98% -$45.6K ﹤0.01% 6649
2021
Q2
$46K Sell
458
-453
-50% -$79.1K ﹤0.01% 5587
2021
Q1
$167K Sell
911
-32
-3% -$7.05K ﹤0.01% 5238
2020
Q4
$324K Buy
+943
New +$222K ﹤0.01% 4828

Other funds holding LONA

Wells Fargo's LONA Position: Q2 2024 in Review

Wells Fargo sold out of LeonaBio Inc (LONA) in Q2 2024, closing a stake of 24 shares — an estimated $652 sold.

Wells Fargo first reported a position in LONA in Q4 2020 and held it in 14 quarters. The position peaked at $354K in Q4 2021. 65 funds tracked by Wall St. Rank hold LONA as of Q2 2024.

  • Wells Fargo reported no remaining LeonaBio Inc position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 24 LeonaBio Inc shares in Q2 2024, an estimated $652.
  • Wells Fargo first reported a position in LeonaBio Inc in Q4 2020 and held it in 14 quarters.
  • Wells Fargo's LeonaBio Inc position peaked at $354K in Q4 2021.
  • 65 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.